StockSignal0009K0
0009K0 · XKRX · Biotechnology · South Korea
Market Capitalization3.85T KRW
52-Week Change26.67 KRW
Aimed Bio Inc. develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases. Its multidisciplinary platform offers antibody-drug conjugates, blood-brain barrier penetration, brain immune modulation, and patient-derived models (PDC/PDX). Aimed Bio Inc. was founded in 2018 and is based in Seoul, South Korea.
Industry
Biotechnology
Healthcare sector · South Korea
Stories
Structural patterns identified in 0009K0
No stories identified yet.
Key Metrics
Market Capitalization
3.85TKRWRevenue (TTM)
29.65BKRWProfit Margin
-145.09%52-Week Change
26.67KRWThis company does not currently pay dividends.
Valuation6
Market Capitalization
3.85TKRWEnterprise Value
3.55TKRWForward P/E
431.65KRWPrice to Sales (TTM)
133.28KRWEnterprise to Revenue
119.56KRWEnterprise to EBITDA
385.19KRWProfitability & Growth10
Profit Margin
-145.09%Operating Margin
-5135.59%Revenue (TTM)
29.65BKRWRevenue per Share (TTM)
734.54KRWQuarterly Revenue Growth
0.0050KRWGross Profit (TTM)
29.65BKRWEBITDA
9.20BKRWNet Income (TTM)
-43.02BKRWOperating Cash Flow (TTM)
26.90BKRWLevered Free Cash Flow (TTM)
0.00KRWFinancial Strength9
Shares Outstanding
64.16MSharesFloat Shares
18.63MKRW% Held by Insiders
0.4055KRW% Held by Institutions
0.1578KRWTotal Cash (MRQ)
167.85BKRWTotal Cash per Share (MRQ)
2.91KKRWTotal Debt (MRQ)
1.11BKRWTotal Debt to Equity (MRQ)
0.6230KRWCurrent Ratio (MRQ)
24.62KRWMarket & Technical7
52-Week Low
42.00KKRW52-Week High
80.20KKRW52-Week Change
26.67KRW50-Day MA
56.31KKRW200-Day MA
57.25KKRWAvg 10-Day Volume
1.55MKRWAvg 30-Day Volume
941.66KKRWCoordination
Placeholder CorpCoordination
Example HoldingsCoordination
Sample IncCoordination